Dolan Michelle M, Singleton Timothy P, Neglia Joseph, Cioc Adina
Department of Laboratory Medicine and Pathology, University of Minnesota, Medical School, Minneapolis 55455, USA.
Am J Clin Pathol. 2006 Dec;126(6):925-30. doi: 10.1309/50GWDKVWU3VWL5XW.
Aplastic anemia (AA) is marrow failure due to an inadequate number of hematopoietic cells in the marrow. Prior reports have described a more aggressive clinical course in aplastic anemia with monosomy 7. We report 3 pediatric cases of AA with normal cytogenetics followed by acquisition of monosomy 7. Bone marrow biopsies were initially diagnostic of AA but later showed monosomy 7 and an increased number of megakaryocytes with small hypolobated nuclei. Immunohistochemical stains for CD61 highlighted the marked dysmegakaryocytopoiesis. The marrow blast percentage was increased in only 1 patient with 4.6% blasts. The 3 patients underwent bone marrow transplantation, and each has remained disease free for 7 to 18 months after transplantation. Pediatric patients with AA and normal cytogenetics may develop monosomy 7 with a myelodysplastic syndrome, unclassified. Patients with AA and monosomy 7 should be evaluated for dysmegakaryocytopoiesis.
再生障碍性贫血(AA)是由于骨髓中造血细胞数量不足导致的骨髓衰竭。既往报道描述了伴有7号染色体单体的再生障碍性贫血临床病程更为侵袭性。我们报告3例细胞遗传学正常的儿童再生障碍性贫血病例,随后出现7号染色体单体。骨髓活检最初诊断为再生障碍性贫血,但后来显示7号染色体单体以及巨核细胞数量增加且核分叶减少。CD61免疫组化染色突出显示了明显的巨核细胞生成异常。仅1例患者骨髓原始细胞百分比增加,为4.6%。这3例患者均接受了骨髓移植,移植后各自无病生存7至18个月。细胞遗传学正常的儿童再生障碍性贫血患者可能会发展为伴有未分类骨髓增生异常综合征的7号染色体单体。伴有7号染色体单体的再生障碍性贫血患者应评估巨核细胞生成异常情况。